-
1
-
-
0037102008
-
Diagnosis and management of vertebral fractures in elderly adults
-
Papaioannou A, Watts NB, Kendler DL, et al. Diagnosis and management of vertebral fractures in elderly adults. Am J Med 2002;113:220-8.
-
(2002)
Am J Med
, vol.113
, pp. 220-228
-
-
Papaioannou, A.1
Watts, N.B.2
Kendler, D.L.3
-
2
-
-
0027324969
-
Population-based study of survival after osteoporotic fractures
-
Cooper C, Atkinson EJ, Jacobsen SJ, et al. Population-based study of survival after osteoporotic fractures. Am J Epidemiol 1993;137:1001-5.
-
(1993)
Am J Epidemiol
, vol.137
, pp. 1001-1005
-
-
Cooper, C.1
Atkinson, E.J.2
Jacobsen, S.J.3
-
3
-
-
0032583492
-
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial
-
Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 1998;280:2077-82.
-
(1998)
JAMA
, vol.280
, pp. 2077-2082
-
-
Cummings, S.R.1
Black, D.M.2
Thompson, D.E.3
-
4
-
-
0033552255
-
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group
-
Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 1999;282:1344-52.
-
(1999)
JAMA
, vol.282
, pp. 1344-1352
-
-
Harris, S.T.1
Watts, N.B.2
Genant, H.K.3
-
5
-
-
4544262219
-
Oral ibandronate osteoporosis vertebral fracture trial in North America and Europe (BONE): Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis
-
Chesnut CH III, Skag A, Christiansen C, et al. Oral ibandronate osteoporosis vertebral fracture trial in North America and Europe (BONE): effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 2004;19:1241-9.
-
(2004)
J Bone Miner Res
, vol.19
, pp. 1241-1249
-
-
Chesnut III, C.H.1
Skag, A.2
Christiansen, C.3
-
6
-
-
0033581212
-
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
-
Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999;282:637-45.
-
(1999)
JAMA
, vol.282
, pp. 637-645
-
-
Ettinger, B.1
Black, D.M.2
Mitlak, B.H.3
-
7
-
-
0035837553
-
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
-
Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.
-
(2001)
N Engl J Med
, vol.344
, pp. 1434-1441
-
-
Neer, R.M.1
Arnaud, C.D.2
Zanchetta, J.R.3
-
8
-
-
25844438772
-
Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: A systematic review of randomized, controlled trials
-
Knopp JA, Diner BM, Blitz M, et al. Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int 2005;16:1281-90.
-
(2005)
Osteoporos Int
, vol.16
, pp. 1281-1290
-
-
Knopp, J.A.1
Diner, B.M.2
Blitz, M.3
-
10
-
-
32944461283
-
Clinical outcomes after acute osteoporotic vertebral fractures: A 2-year no-randomized trial comparing percutaneous vertebroplasty with conservative therapy
-
Diamond TH, Bryant C, Browne L, et al. Clinical outcomes after acute osteoporotic vertebral fractures: a 2-year no-randomized trial comparing percutaneous vertebroplasty with conservative therapy. Med J Aust 2006;184:113-7.
-
(2006)
Med J Aust
, vol.184
, pp. 113-117
-
-
Diamond, T.H.1
Bryant, C.2
Browne, L.3
-
11
-
-
13444265876
-
Predictors of outcomes of percutaneous vertebroplasty for osteoporotic vertebral fractures
-
Alvarez L, Perez-Higueras A, Granizo JJ, et al. Predictors of outcomes of percutaneous vertebroplasty for osteoporotic vertebral fractures. Spine 2005;30:87-92.
-
(2005)
Spine
, vol.30
, pp. 87-92
-
-
Alvarez, L.1
Perez-Higueras, A.2
Granizo, J.J.3
-
12
-
-
24344501770
-
Prospective analysis of clinical outcomes after percutaneous vertebroplasty for painful osteoporotic vertebral body fractures
-
Do HM, Kim BS, Marcellus ML, et al. Prospective analysis of clinical outcomes after percutaneous vertebroplasty for painful osteoporotic vertebral body fractures. AJNR Am J Neuroradiol 2005;26:1623-8.
-
(2005)
AJNR Am J Neuroradiol
, vol.26
, pp. 1623-1628
-
-
Do, H.M.1
Kim, B.S.2
Marcellus, M.L.3
-
13
-
-
33646590937
-
Percutaneous vertebroplasty: Functional improvement in patients with osteoporotic compression fractures
-
Álvarez L, Alcaraz M, Pérez-Higueras A, et al. Percutaneous vertebroplasty: functional improvement in patients with osteoporotic compression fractures. Spine 2006;31:1113-8.
-
(2006)
Spine
, vol.31
, pp. 1113-1118
-
-
Álvarez, L.1
Alcaraz, M.2
Pérez-Higueras, A.3
-
14
-
-
40349116694
-
-
Accessed October 23, 2006
-
http://www.mrc-bsu.cam.ac.uk/bugs/winbugs (Accessed October 23, 2006).
-
-
-
-
15
-
-
0030585482
-
Practice variations and the challenge to leadership
-
Wennberg JE. Practice variations and the challenge to leadership. Spine 1996;21:910-6.
-
(1996)
Spine
, vol.21
, pp. 910-916
-
-
Wennberg, J.E.1
-
16
-
-
0031744015
-
Variation profiles of common surgical procedures
-
Birkmeyer JD, Sharp SM, Finlayson SR, et al. Variation profiles of common surgical procedures. Surgery 1998;124:917-23.
-
(1998)
Surgery
, vol.124
, pp. 917-923
-
-
Birkmeyer, J.D.1
Sharp, S.M.2
Finlayson, S.R.3
-
17
-
-
40349096850
-
-
Accessed October 23, 2006
-
http://www.dartmouthatlas.org/index.shtm (Accessed October 23, 2006).
-
-
-
-
18
-
-
0027932349
-
Hospital re-admission rates for cohorts of Medicare beneficiaries in Boston and New Haven
-
Fisher ES, Wennberg JE, Stuekel TA, et al. Hospital re-admission rates for cohorts of Medicare beneficiaries in Boston and New Haven. N Engl J Med 1994;331:989-95.
-
(1994)
N Engl J Med
, vol.331
, pp. 989-995
-
-
Fisher, E.S.1
Wennberg, J.E.2
Stuekel, T.A.3
-
19
-
-
33646802964
-
Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable
-
Brookhart MA, Wang PS, Solomon DH, et al. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology 2006;17:268-75.
-
(2006)
Epidemiology
, vol.17
, pp. 268-275
-
-
Brookhart, M.A.1
Wang, P.S.2
Solomon, D.H.3
-
20
-
-
33846436128
-
Analysis of observational studies in the presence of treatment selection bias
-
Stukel TA, Fisher ES, Wennberg DE, et al. Analysis of observational studies in the presence of treatment selection bias. JAMA 2007;297:278-85.
-
(2007)
JAMA
, vol.297
, pp. 278-285
-
-
Stukel, T.A.1
Fisher, E.S.2
Wennberg, D.E.3
|